VANYA LYDAY: Open Payments
NPI 1871830299 · SUNNYVALE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 18 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $273 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $175 |
| Blueprint Medicines Corporation | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| GENZYME CORPORATION | 2 | $53 |
| Lilly USA, LLC | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
Products named: AYVAKIT, DUPIXENT, AIRSUPRA, TEZSPIRE, EBGLYSS, XOLAIR, Rhapsido.
Industry payments across TX — which companies pay providers there.
